Proviron (Mesterolone) 25 mg – 100 Tablets

Biochem Proviron (Mesterolone) 25 mg – Oral Androgen Tablets

Biochem Proviron (Mesterolone) 25 mg – 100 Tablets is a product containing mesterolone, a synthetic orally active androgen derived from dihydrotestosterone (DHT). Mesterolone belongs to the androgenic steroid class and has historically been used in selected medical settings involving male androgen deficiency and certain reproductive conditions.

Mesterolone became commercially associated with the pharmaceutical brand name Proviron. Unlike many anabolic-androgenic steroids developed primarily for anabolic effects, mesterolone is characterized by predominantly androgenic activity and relatively limited anabolic effects in skeletal muscle.

Its molecular structure contains a methyl group at carbon 1 in the alpha configuration, distinguishing it from testosterone and dihydrotestosterone. This structural modification contributes to its oral activity and pharmacological properties.

Mesterolone is a 1-alpha-methylated DHT derivative, not a 17-alpha-alkylated anabolic steroid like methandrostenolone or oxandrolone. This distinction is relevant to its metabolism and hepatic effects, although it does not establish that mesterolone is free from liver-related risks.

Unlike testosterone, mesterolone is not converted into estrogen through aromatase activity. Its nonaromatizing structure contributes to its distinct endocrine profile, but it does not make the compound an established estrogen-lowering treatment.

Mesterolone acts primarily through androgen receptors in responsive tissues. Androgen receptor activation influences gene transcription and physiological processes involved in male reproductive development, sexual function, and androgen-dependent tissue regulation.

Mesterolone also demonstrates substantial binding to sex hormone-binding globulin (SHBG). Its interaction with SHBG has been investigated in relation to androgen transport and circulating hormone fractions, although changes in SHBG binding do not necessarily translate into predictable improvements in testosterone status or clinical outcomes.

Pharmaceutical mesterolone has historically been used in certain countries for selected forms of male androgen deficiency and reproductive disorders. These applications are dependent on local regulatory authorization and clinical evaluation.

Proviron is a pharmaceutical brand name associated with mesterolone. The use of this name in a Biochem product description does not establish that a Biochem-labeled product is authentic branded Proviron or therapeutically equivalent to an authorized pharmaceutical preparation.

The Biochem Mesterolone product is described as containing 25 mg per tablet, with 100 tablets per package. The stated strength represents the labeled amount of active ingredient per tablet and does not constitute an individual dosage recommendation. The product's identity, purity, excipients, and manufacturing specifications have not been independently verified.

1. Activates Androgen Receptors

Mesterolone interacts with intracellular androgen receptors expressed in male reproductive tissues, skin, skeletal muscle, and other androgen-responsive structures.

Following receptor activation, the androgen receptor complex influences transcriptional processes associated with androgen-dependent physiological functions.

Its pharmacological effects are primarily associated with androgen receptor activity rather than direct stimulation of testosterone synthesis.

2. Has Predominantly Androgenic Biological Activity

Mesterolone is classified as an androgenic steroid with relatively limited anabolic effects compared with many other anabolic-androgenic steroids.

Its tissue-specific activity reflects its DHT-derived structure, metabolism, and interaction with androgen receptors.

Androgenic activity can influence secondary sexual characteristics and other androgen-dependent physiological processes, but these effects do not establish that mesterolone is appropriate for cosmetic or performance-enhancement purposes.

3. Interacts with Sex Hormone-Binding Globulin

Mesterolone has a relatively high affinity for sex hormone-binding globulin, a circulating protein involved in binding testosterone, dihydrotestosterone, and estradiol.

Competition for SHBG binding sites can influence measured or calculated hormone fractions under certain conditions.

However, SHBG interactions do not guarantee an increase in biologically active testosterone or improvement in symptoms of androgen deficiency.

4. Does Not Undergo Aromatization to Estrogen

Mesterolone is not converted into estrogen by the aromatase enzyme.

This distinguishes it from aromatizable androgens such as testosterone and methandrostenolone.

The absence of aromatization does not establish that mesterolone reliably lowers circulating estrogen concentrations or prevents estrogen-related adverse effects caused by other substances.

5. Has Been Studied in Male Reproductive and Endocrine Conditions

Pharmaceutical mesterolone has historically been evaluated in selected male endocrine and reproductive conditions.

Its medical use has varied among countries, and evidence supporting particular indications is not uniform.

Mesterolone should not be described as a universally effective treatment for infertility, low testosterone, or sexual dysfunction.

6. Has Distinct Hepatic Metabolic Characteristics

Mesterolone is 1-alpha-methylated rather than 17-alpha-alkylated.

This structural distinction affects its metabolism and differentiates it from certain orally active anabolic steroids associated with substantial hepatic toxicity.

Nevertheless, hepatic metabolism and the possibility of adverse effects remain relevant, particularly in individuals with existing liver disease or other medical conditions.

7. Influences Androgen-Dependent Endocrine Regulation

Mesterolone produces androgenic effects through activation of androgen receptors and interaction with circulating hormone-binding proteins.

Exogenous androgen exposure can influence endocrine feedback mechanisms, and its effects on gonadotropins and endogenous testosterone production depend on exposure and individual physiology.

Mesterolone may also affect lipid metabolism and other cardiovascular risk factors.

Mesterolone carries clinically important risks, including androgenic adverse effects, acne, changes in hair growth, scalp hair loss in susceptible individuals, potential prostate-related complications, lipid abnormalities, and possible endocrine disturbances. Prolonged or inappropriate androgen exposure may affect reproductive function. Androgens can also cause fetal harm and virilization and are generally inappropriate during pregnancy. Individuals with known or suspected prostate cancer or certain other androgen-sensitive conditions require particular caution.

The 25 mg tablet strength represents the labeled quantity of mesterolone per tablet. It does not establish an appropriate dose, treatment duration, or safe exposure level.

Mesterolone is an orally active synthetic androgen whose principal biological activity involves androgen receptor activation and regulation of androgen-responsive gene transcription.

Its pharmacological profile differs from testosterone esters, aromatizable anabolic steroids, peptide hormones, and growth hormone secretagogues because of its DHT-derived structure, limited aromatization potential, and interactions with SHBG.

Step 1 – Oral Administration and Gastrointestinal Absorption

In established pharmaceutical tablet formulations, mesterolone is administered orally and absorbed through the gastrointestinal tract.

Its 1-alpha-methyl structural modification contributes to its oral pharmacological activity.

Absorption characteristics depend on the pharmaceutical formulation and individual physiological factors.

Step 2 – Distribution and Binding to Circulating Proteins

Following absorption, mesterolone enters systemic circulation and interacts with circulating proteins, including sex hormone-binding globulin.

Protein binding influences the distribution of the compound and its availability to androgen-responsive tissues.

Step 3 – Binding to Intracellular Androgen Receptors

Mesterolone reaches androgen-responsive tissues and interacts with intracellular androgen receptors.

The resulting receptor activation influences androgen-dependent cellular signaling and gene expression.

The biological response depends on receptor expression, tissue characteristics, systemic exposure, and individual endocrine status.

Step 4 – Regulation of Androgen-Responsive Gene Expression

Activated androgen receptors participate in the regulation of transcriptional processes associated with male reproductive physiology, tissue function, and other androgen-dependent activities.

Mesterolone does not undergo aromatization to estrogen, distinguishing its metabolic profile from that of testosterone.

Its interaction with SHBG may also influence circulating hormone-binding dynamics.

Step 5 – Hepatic Metabolism and Elimination

Mesterolone undergoes metabolic processing involving the liver and is eliminated through physiological excretory pathways.

The terminal elimination half-life has been reported at approximately 12–13 hours in certain pharmacokinetic studies, although estimates may vary.

These pharmacokinetic observations relate to studied pharmaceutical preparations and do not independently establish the characteristics of a particular Biochem-labeled product.

Mesterolone is commonly associated with oral solid-dose formulations rather than injectable oil-based androgen preparations.

Their formulation characteristics may include:

• Mesterolone as the labeled active ingredient.
• A labeled strength of 25 mg per tablet.
• A package quantity of 100 tablets.
• A synthetic dihydrotestosterone-derived androgen structure.
• A 1-alpha-methyl structural modification.
• Androgen receptor agonist activity.
• Predominantly androgenic biological effects.
• Relatively limited anabolic activity.
• Absence of aromatization to estrogen.
• Significant interaction with sex hormone-binding globulin.
• Oral solid-dose pharmaceutical presentation.
• Excipients selected for tablet manufacture and stability.
• Formulation-dependent dissolution and absorption characteristics.
• Packaging designed to protect tablets from environmental exposure.
• Identity, purity, and content uniformity requiring analytical verification.

The precise formulation, excipient composition, tablet appearance, and manufacturing specifications of Biochem Proviron 25 mg have not been confirmed.

The presence of 100 tablets does not establish an appropriate treatment duration or individual prescription. The Biochem product should not be represented as authentic branded Proviron or as an approved interchangeable generic without independent verification.

United States

Biochem Proviron 25mg, Biochem Mesterolone 25mg, Proviron 100 tablets, Mesterolone 100 tablets, Mesterolone 25mg United States, Proviron oral tablets, Mesterolone androgen information, Mesterolone DHT derivative, Proviron properties, Mesterolone description, Proviron pharmacology, Mesterolone mechanism of action, Mesterolone androgen receptor, Proviron SHBG binding, Mesterolone molecular formula, Mesterolone chemical structure, Mesterolone elimination half life, Mesterolone liver metabolism, Proviron historical medical uses, Mesterolone safety information, Proviron tablet specifications.

Canada

English: Biochem Proviron 25mg Canada, Mesterolone 25mg Canada, Proviron 100 tablets Canada, Mesterolone oral tablets, Mesterolone androgen, Proviron properties, Mesterolone pharmacology, Proviron androgen receptor, Mesterolone SHBG binding, Mesterolone molecular structure, Proviron mechanism of action, Mesterolone safety information.

French: Biochem Proviron 25 mg Canada, mestérolone 25 mg, Proviron 100 comprimés, androgène oral, propriétés de la mestérolone, pharmacologie du Proviron, récepteur des androgènes, liaison à la SHBG, structure moléculaire de la mestérolone, métabolisme hépatique, mécanisme d'action du Proviron, composition des comprimés.

United Kingdom

Biochem Proviron 25mg UK, Mesterolone 25mg UK, Proviron 100 tablets UK, Mesterolone oral androgen, Proviron properties, Mesterolone pharmacology, Proviron androgen receptor, Mesterolone SHBG binding, Proviron molecular composition, Mesterolone mechanism of action, Proviron liver metabolism, Mesterolone historical clinical information, Proviron tablet formulation.

Germany

Biochem Proviron 25 mg Deutschland, Mesterolon 25 mg, Proviron 100 Tabletten, orales Androgen, Mesterolon Eigenschaften, Proviron Wirkungsmechanismus, Mesterolon Zusammensetzung, Androgenrezeptor, SHBG Bindung, androgene Wirkung, DHT Derivat, Mesterolon Molekülstruktur, Leberstoffwechsel, Mesterolon Halbwertszeit, Proviron Sicherheitsinformationen.

France

Biochem Proviron 25 mg France, mestérolone 25 mg, Proviron 100 comprimés, androgène oral, propriétés de la mestérolone, mécanisme d'action du Proviron, composition de la mestérolone, récepteur des androgènes, liaison à la SHBG, activité androgénique, dérivé de la DHT, structure moléculaire, métabolisme hépatique, demi-vie de la mestérolone, informations de sécurité.

Spain

Biochem Proviron 25 mg España, mesterolona 25 mg, Proviron 100 tabletas, andrógeno oral, propiedades de la mesterolona, cómo funciona el Proviron, composición de la mesterolona, receptor de andrógenos, unión a la SHBG, actividad androgénica, derivado de DHT, estructura molecular, metabolismo hepático, vida media de la mesterolona, mecanismo de acción del Proviron.

Italy

Biochem Proviron 25 mg Italia, mesterolone 25 mg, Proviron 100 compresse, androgeno orale, proprietà del mesterolone, meccanismo d'azione Proviron, composizione del mesterolone, recettore degli androgeni, legame con SHBG, attività androgenica, derivato del DHT, struttura molecolare, metabolismo epatico, emivita del mesterolone, informazioni di sicurezza.

Portugal

Biochem Proviron 25 mg Portugal, mesterolona 25 mg, Proviron 100 comprimidos, androgénio oral, propriedades da mesterolona, mecanismo de ação do Proviron, composição da mesterolona, recetor de androgénios, ligação à SHBG, atividade androgénica, derivado de DHT, estrutura molecular, metabolismo hepático, meia-vida da mesterolona, informações de segurança.

Netherlands

Biochem Proviron 25 mg Nederland, mesterolon 25 mg, Proviron 100 tabletten, oraal androgeen, eigenschappen van mesterolon, werkingsmechanisme Proviron, samenstelling van mesterolon, androgeenreceptor, SHBG binding, androgene activiteit, DHT derivaat, moleculaire structuur, levermetabolisme, halfwaardetijd mesterolon, veiligheidsinformatie.

Belgium

Biochem Proviron 25 mg Belgium, mesterolon 25 mg België, mestérolone 25 mg Belgique, Proviron 100 tabletten, Proviron 100 comprimés, oraal androgeen, androgène oral, eigenschappen van mesterolon, propriétés de la mestérolone, androgeenreceptor, récepteur des androgènes, SHBG binding, liaison à la SHBG, levermetabolisme, métabolisme hépatique, werkingsmechanisme Proviron.

Switzerland

Biochem Proviron 25 mg Switzerland, Mesterolon 25 mg Schweiz, mestérolone 25 mg Suisse, Proviron 100 Tabletten, Proviron 100 comprimés, orales Androgen, androgène oral, Mesterolon Eigenschaften, propriétés de la mestérolone, Androgenrezeptor, récepteur des androgènes, SHBG Bindung, liaison à la SHBG, Leberstoffwechsel, métabolisme hépatique, Proviron Wirkungsmechanismus.

Austria

Biochem Proviron 25 mg Österreich, Mesterolon 25 mg, Proviron 100 Tabletten, orales Androgen, Mesterolon Eigenschaften, Proviron Wirkungsmechanismus, Androgenrezeptor, SHBG Bindung, androgene Wirkung, DHT Derivat, Molekülstruktur, Leberstoffwechsel, Mesterolon Halbwertszeit, Proviron Zusammensetzung, Sicherheitsinformationen.

Sweden

Biochem Proviron 25 mg Sverige, mesterolon 25 mg, Proviron 100 tabletter, oralt androgen, mesterolon egenskaper, Proviron verkningsmekanism, androgenreceptor, SHBG bindning, androgen aktivitet, DHT derivat, molekylstruktur, levermetabolism, mesterolon halveringstid, Proviron farmakologi, säkerhetsinformation.

Norway

Biochem Proviron 25 mg Norge, mesterolon 25 mg, Proviron 100 tabletter, oralt androgen, mesterolon egenskaper, Proviron virkningsmekanisme, androgenreseptor, SHBG binding, androgen aktivitet, DHT derivat, molekylstruktur, levermetabolisme, mesterolon halveringstid, Proviron farmakologi, sikkerhetsinformasjon.

Denmark

Biochem Proviron 25 mg Danmark, mesterolon 25 mg, Proviron 100 tabletter, oralt androgen, mesterolon egenskaber, Proviron virkningsmekanisme, androgenreceptor, SHBG binding, androgen aktivitet, DHT derivat, molekylstruktur, levermetabolisme, mesterolon halveringstid, Proviron farmakologi, sikkerhedsinformation.

Finland

Biochem Proviron 25 mg Suomi, mesteroloni 25 mg, Proviron 100 tablettia, suun kautta otettava androgeeni, mesterolonin ominaisuudet, Proviron vaikutusmekanismi, androgeenireseptori, SHBG sitoutuminen, androgeeninen aktiivisuus, DHT johdannainen, molekyylirakenne, maksametabolia, mesterolonin puoliintumisaika, Proviron farmakologia, turvallisuustiedot.

Poland

Biochem Proviron 25 mg Polska, mesterolon 25 mg, Proviron 100 tabletek, doustny androgen, właściwości mesterolonu, mechanizm działania Proviron, skład mesterolonu, receptor androgenowy, wiązanie SHBG, aktywność androgenna, pochodna DHT, struktura molekularna, metabolizm wątrobowy, okres półtrwania mesterolonu, informacje o bezpieczeństwie.

Czech Republic

Biochem Proviron 25 mg Česko, mesterolon 25 mg, Proviron 100 tablet, perorální androgen, vlastnosti mesterolonu, mechanismus účinku Proviron, složení mesterolonu, androgenový receptor, vazba na SHBG, androgenní aktivita, derivát DHT, molekulární struktura, jaterní metabolismus, poločas mesterolonu, bezpečnostní informace.

Romania

Biochem Proviron 25 mg România, mesterolon 25 mg, Proviron 100 comprimate, androgen oral, proprietăți mesterolon, mecanism de acțiune Proviron, compoziția mesterolonului, receptor androgenic, legarea de SHBG, activitate androgenică, derivat DHT, structură moleculară, metabolism hepatic, timpul de înjumătățire al mesterolonului, informații de siguranță.

Greece

Biochem Proviron 25 mg Ελλάδα, μεστερολόνη 25 mg, Proviron 100 δισκία, ανδρογόνο από του στόματος, ιδιότητες μεστερολόνης, μηχανισμός δράσης Proviron, σύνθεση μεστερολόνης, υποδοχέας ανδρογόνων, σύνδεση με SHBG, ανδρογονική δραστηριότητα, παράγωγο DHT, μοριακή δομή, ηπατικός μεταβολισμός, χρόνος ημιζωής μεστερολόνης, πληροφορίες ασφάλειας.

Ireland

Biochem Proviron 25mg Ireland, Mesterolone 25mg Ireland, Proviron 100 tablets Ireland, Mesterolone oral androgen, Proviron properties, Mesterolone pharmacology, Proviron androgen receptor, Mesterolone SHBG binding, Proviron molecular composition, Mesterolone mechanism of action, Proviron liver metabolism, Mesterolone historical clinical information, Proviron tablet formulation.

Colombia

Biochem Proviron 25 mg Colombia, mesterolona 25 mg Colombia, Proviron 100 tabletas, andrógeno oral, propiedades de la mesterolona, cómo funciona el Proviron, farmacología de la mesterolona, composición del Proviron, receptor de andrógenos, unión a la SHBG, actividad androgénica, derivado de DHT, estructura molecular, metabolismo hepático, vida media de la mesterolona, mecanismo de acción del Proviron, información de seguridad.

Argentina

Biochem Proviron 25 mg Argentina, mesterolona 25 mg Argentina, Proviron 100 comprimidos, andrógeno oral, propiedades de la mesterolona, qué es el Proviron, cómo actúa la mesterolona, farmacología del Proviron, receptor de andrógenos, unión a la SHBG, actividad androgénica, derivado de DHT, estructura molecular, metabolismo hepático, vida media de la mesterolona, composición del Proviron.

México

Biochem Proviron 25 mg México, mesterolona 25 mg México, Proviron 100 tabletas, andrógeno oral, propiedades de la mesterolona, para qué se ha utilizado el Proviron, cómo funciona la mesterolona, farmacología del Proviron, receptor de andrógenos, unión a la SHBG, actividad androgénica, derivado de DHT, estructura molecular, metabolismo hepático, vida